RxDoctor Payments Data

Timothy Kaminski

Psychiatric/Mental Health · Toledo, OHNPI 1912324252

Payments from drug & device makers

$1,648in general payments, 2019–2025

Across 89 payments — averaging $18.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$615
  • AbbVie$319
  • Indivior Inc.$162
  • Alkermes, Inc.$126
  • Johnson & Johnson$98
  • E.r. Squibb & Sons, L.L.C.$82
  • plus $247 from 7 others

What the payments were for

  • Food & beverage$1,648100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,648 in reported general payments places this provider in the 70th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$6,409
Medicare patients
15
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate24$85,072
VraylarCariprazine Hcl38$57,078
AuvelityDextromethorphan Hbr/Bupropion11$11,104
Desvenlafaxine Succinate ErDesvenlafaxine Succinate26$3,040
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl30$2,828
SuboxoneBuprenorphine Hcl/Naloxone Hcl13$1,815
Buspirone Hcl48$1,354
Paliperidone ErPaliperidone17$1,170
Oxcarbazepine21$1,039
Divalproex Sodium ErDivalproex Sodium17$1,007
Mirtazapine51$929
Hydroxyzine Pamoate56$747
Trazodone Hcl77$740
Duloxetine Hcl33$579
Quetiapine Fumarate50$570

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$98$85,07224 claims
AbbVieVraylar$319$57,07838 claims
Axsome Therapeutics, Inc.Auvelity$42$11,10411 claims
Indivior Inc.Suboxone$162$1,81513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →